Global Oral Antidiabetic Drugs Market Growth 2022-2028
The report requires updating with new data and is sent in 48 hours after order is placed.
As the global economy mends, the 2021 growth of Oral Antidiabetic Drugs will have significant change from previous year. According to our (LP Information) latest study, the global Oral Antidiabetic Drugs market size is USD million in 2022 from USD 1803.9 million in 2021, with a change of % between 2021 and 2022. The global Oral Antidiabetic Drugs market size will reach USD 2251.3 million in 2028, growing at a CAGR of 3.2% over the analysis period.
The United States Oral Antidiabetic Drugs market is expected at value of US$ million in 2021 and grow at approximately % CAGR during review period. China constitutes a % market for the global Oral Antidiabetic Drugs market, reaching US$ million by the year 2028. As for the Europe Oral Antidiabetic Drugs landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period. In APAC, the growth rates of other notable markets (Japan and South Korea) are projected to be at % and % respectively for the next 5-year period.
Global main Oral Antidiabetic Drugs players cover Eli Lilly, Abbott, Biocon, and Sanofi, etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.
This report presents a comprehensive overview, market shares, and growth opportunities of Oral Antidiabetic Drugs market by product type, application, key manufacturers and key regions and countries.
Segmentation by type: breakdown data from 2017 to 2022, in Section 2.3; and forecast to 2028 in section 12.6
As the global economy mends, the 2021 growth of Oral Antidiabetic Drugs will have significant change from previous year. According to our (LP Information) latest study, the global Oral Antidiabetic Drugs market size is USD million in 2022 from USD 1803.9 million in 2021, with a change of % between 2021 and 2022. The global Oral Antidiabetic Drugs market size will reach USD 2251.3 million in 2028, growing at a CAGR of 3.2% over the analysis period.
The United States Oral Antidiabetic Drugs market is expected at value of US$ million in 2021 and grow at approximately % CAGR during review period. China constitutes a % market for the global Oral Antidiabetic Drugs market, reaching US$ million by the year 2028. As for the Europe Oral Antidiabetic Drugs landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period. In APAC, the growth rates of other notable markets (Japan and South Korea) are projected to be at % and % respectively for the next 5-year period.
Global main Oral Antidiabetic Drugs players cover Eli Lilly, Abbott, Biocon, and Sanofi, etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.
This report presents a comprehensive overview, market shares, and growth opportunities of Oral Antidiabetic Drugs market by product type, application, key manufacturers and key regions and countries.
Segmentation by type: breakdown data from 2017 to 2022, in Section 2.3; and forecast to 2028 in section 12.6
- Sulfonylureas
- Meglitinides
- Alpha-glucosidase inhibitors
- Hospitals
- Clinics
- Others
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- Eli Lilly
- Abbott
- Biocon
- Sanofi
- Sunpharma
- Novartis
- Novo Nordisk
- Merck
- Pfizer
- Huadong Medicine Co.,Ltd.
- Lepu Medical
- Hengrui Medicine
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Oral Antidiabetic Drugs Annual Sales 2017-2028
2.1.2 World Current & Future Analysis for Oral Antidiabetic Drugs by Geographic Region, 2017, 2022 & 2028
2.1.3 World Current & Future Analysis for Oral Antidiabetic Drugs by Country/Region, 2017, 2022 & 2028
2.2 Oral Antidiabetic Drugs Segment by Type
2.2.1 Sulfonylureas
2.2.2 Meglitinides
2.2.3 Alpha-glucosidase inhibitors
2.3 Oral Antidiabetic Drugs Sales by Type
2.3.1 Global Oral Antidiabetic Drugs Sales Market Share by Type (2017-2022)
2.3.2 Global Oral Antidiabetic Drugs Revenue and Market Share by Type (2017-2022)
2.3.3 Global Oral Antidiabetic Drugs Sale Price by Type (2017-2022)
2.4 Oral Antidiabetic Drugs Segment by Application
2.4.1 Hospitals
2.4.2 Clinics
2.4.3 Others
2.5 Oral Antidiabetic Drugs Sales by Application
2.5.1 Global Oral Antidiabetic Drugs Sale Market Share by Application (2017-2022)
2.5.2 Global Oral Antidiabetic Drugs Revenue and Market Share by Application (2017-2022)
2.5.3 Global Oral Antidiabetic Drugs Sale Price by Application (2017-2022)
3 GLOBAL ORAL ANTIDIABETIC DRUGS BY COMPANY
3.1 Global Oral Antidiabetic Drugs Breakdown Data by Company
3.1.1 Global Oral Antidiabetic Drugs Annual Sales by Company (2020-2022)
3.1.2 Global Oral Antidiabetic Drugs Sales Market Share by Company (2020-2022)
3.2 Global Oral Antidiabetic Drugs Annual Revenue by Company (2020-2022)
3.2.1 Global Oral Antidiabetic Drugs Revenue by Company (2020-2022)
3.2.2 Global Oral Antidiabetic Drugs Revenue Market Share by Company (2020-2022)
3.3 Global Oral Antidiabetic Drugs Sale Price by Company
3.4 Key Manufacturers Oral Antidiabetic Drugs Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Oral Antidiabetic Drugs Product Location Distribution
3.4.2 Players Oral Antidiabetic Drugs Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 WORLD HISTORIC REVIEW FOR ORAL ANTIDIABETIC DRUGS BY GEOGRAPHIC REGION
4.1 World Historic Oral Antidiabetic Drugs Market Size by Geographic Region (2017-2022)
4.1.1 Global Oral Antidiabetic Drugs Annual Sales by Geographic Region (2017-2022)
4.1.2 Global Oral Antidiabetic Drugs Annual Revenue by Geographic Region
4.2 World Historic Oral Antidiabetic Drugs Market Size by Country/Region (2017-2022)
4.2.1 Global Oral Antidiabetic Drugs Annual Sales by Country/Region (2017-2022)
4.2.2 Global Oral Antidiabetic Drugs Annual Revenue by Country/Region
4.3 Americas Oral Antidiabetic Drugs Sales Growth
4.4 APAC Oral Antidiabetic Drugs Sales Growth
4.5 Europe Oral Antidiabetic Drugs Sales Growth
4.6 Middle East & Africa Oral Antidiabetic Drugs Sales Growth
5 AMERICAS
5.1 Americas Oral Antidiabetic Drugs Sales by Country
5.1.1 Americas Oral Antidiabetic Drugs Sales by Country (2017-2022)
5.1.2 Americas Oral Antidiabetic Drugs Revenue by Country (2017-2022)
5.2 Americas Oral Antidiabetic Drugs Sales by Type
5.3 Americas Oral Antidiabetic Drugs Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Oral Antidiabetic Drugs Sales by Region
6.1.1 APAC Oral Antidiabetic Drugs Sales by Region (2017-2022)
6.1.2 APAC Oral Antidiabetic Drugs Revenue by Region (2017-2022)
6.2 APAC Oral Antidiabetic Drugs Sales by Type
6.3 APAC Oral Antidiabetic Drugs Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Oral Antidiabetic Drugs by Country
7.1.1 Europe Oral Antidiabetic Drugs Sales by Country (2017-2022)
7.1.2 Europe Oral Antidiabetic Drugs Revenue by Country (2017-2022)
7.2 Europe Oral Antidiabetic Drugs Sales by Type
7.3 Europe Oral Antidiabetic Drugs Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Oral Antidiabetic Drugs by Country
8.1.1 Middle East & Africa Oral Antidiabetic Drugs Sales by Country (2017-2022)
8.1.2 Middle East & Africa Oral Antidiabetic Drugs Revenue by Country (2017-2022)
8.2 Middle East & Africa Oral Antidiabetic Drugs Sales by Type
8.3 Middle East & Africa Oral Antidiabetic Drugs Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Oral Antidiabetic Drugs
10.3 Manufacturing Process Analysis of Oral Antidiabetic Drugs
10.4 Industry Chain Structure of Oral Antidiabetic Drugs
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Oral Antidiabetic Drugs Distributors
11.3 Oral Antidiabetic Drugs Customer
12 WORLD FORECAST REVIEW FOR ORAL ANTIDIABETIC DRUGS BY GEOGRAPHIC REGION
12.1 Global Oral Antidiabetic Drugs Market Size Forecast by Region
12.1.1 Global Oral Antidiabetic Drugs Forecast by Region (2023-2028)
12.1.2 Global Oral Antidiabetic Drugs Annual Revenue Forecast by Region (2023-2028)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Oral Antidiabetic Drugs Forecast by Type
12.7 Global Oral Antidiabetic Drugs Forecast by Application
13 KEY PLAYERS ANALYSIS
13.1 Eli Lilly
13.1.1 Eli Lilly Company Information
13.1.2 Eli Lilly Oral Antidiabetic Drugs Product Offered
13.1.3 Eli Lilly Oral Antidiabetic Drugs Sales, Revenue, Price and Gross Margin (2020-2022)
13.1.4 Eli Lilly Main Business Overview
13.1.5 Eli Lilly Latest Developments
13.2 Abbott
13.2.1 Abbott Company Information
13.2.2 Abbott Oral Antidiabetic Drugs Product Offered
13.2.3 Abbott Oral Antidiabetic Drugs Sales, Revenue, Price and Gross Margin (2020-2022)
13.2.4 Abbott Main Business Overview
13.2.5 Abbott Latest Developments
13.3 Biocon
13.3.1 Biocon Company Information
13.3.2 Biocon Oral Antidiabetic Drugs Product Offered
13.3.3 Biocon Oral Antidiabetic Drugs Sales, Revenue, Price and Gross Margin (2020-2022)
13.3.4 Biocon Main Business Overview
13.3.5 Biocon Latest Developments
13.4 Sanofi
13.4.1 Sanofi Company Information
13.4.2 Sanofi Oral Antidiabetic Drugs Product Offered
13.4.3 Sanofi Oral Antidiabetic Drugs Sales, Revenue, Price and Gross Margin (2020-2022)
13.4.4 Sanofi Main Business Overview
13.4.5 Sanofi Latest Developments
13.5 Sunpharma
13.5.1 Sunpharma Company Information
13.5.2 Sunpharma Oral Antidiabetic Drugs Product Offered
13.5.3 Sunpharma Oral Antidiabetic Drugs Sales, Revenue, Price and Gross Margin (2020-2022)
13.5.4 Sunpharma Main Business Overview
13.5.5 Sunpharma Latest Developments
13.6 Novartis
13.6.1 Novartis Company Information
13.6.2 Novartis Oral Antidiabetic Drugs Product Offered
13.6.3 Novartis Oral Antidiabetic Drugs Sales, Revenue, Price and Gross Margin (2020-2022)
13.6.4 Novartis Main Business Overview
13.6.5 Novartis Latest Developments
13.7 Novo Nordisk
13.7.1 Novo Nordisk Company Information
13.7.2 Novo Nordisk Oral Antidiabetic Drugs Product Offered
13.7.3 Novo Nordisk Oral Antidiabetic Drugs Sales, Revenue, Price and Gross Margin (2020-2022)
13.7.4 Novo Nordisk Main Business Overview
13.7.5 Novo Nordisk Latest Developments
13.8 Merck
13.8.1 Merck Company Information
13.8.2 Merck Oral Antidiabetic Drugs Product Offered
13.8.3 Merck Oral Antidiabetic Drugs Sales, Revenue, Price and Gross Margin (2020-2022)
13.8.4 Merck Main Business Overview
13.8.5 Merck Latest Developments
13.9 Pfizer
13.9.1 Pfizer Company Information
13.9.2 Pfizer Oral Antidiabetic Drugs Product Offered
13.9.3 Pfizer Oral Antidiabetic Drugs Sales, Revenue, Price and Gross Margin (2020-2022)
13.9.4 Pfizer Main Business Overview
13.9.5 Pfizer Latest Developments
13.10 Huadong Medicine Co.,Ltd.
13.10.1 Huadong Medicine Co.,Ltd. Company Information
13.10.2 Huadong Medicine Co.,Ltd. Oral Antidiabetic Drugs Product Offered
13.10.3 Huadong Medicine Co.,Ltd. Oral Antidiabetic Drugs Sales, Revenue, Price and Gross Margin (2020-2022)
13.10.4 Huadong Medicine Co.,Ltd. Main Business Overview
13.10.5 Huadong Medicine Co.,Ltd. Latest Developments
13.11 Lepu Medical
13.11.1 Lepu Medical Company Information
13.11.2 Lepu Medical Oral Antidiabetic Drugs Product Offered
13.11.3 Lepu Medical Oral Antidiabetic Drugs Sales, Revenue, Price and Gross Margin (2020-2022)
13.11.4 Lepu Medical Main Business Overview
13.11.5 Lepu Medical Latest Developments
13.12 Hengrui Medicine
13.12.1 Hengrui Medicine Company Information
13.12.2 Hengrui Medicine Oral Antidiabetic Drugs Product Offered
13.12.3 Hengrui Medicine Oral Antidiabetic Drugs Sales, Revenue, Price and Gross Margin (2020-2022)
13.12.4 Hengrui Medicine Main Business Overview
13.12.5 Hengrui Medicine Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Oral Antidiabetic Drugs Annual Sales 2017-2028
2.1.2 World Current & Future Analysis for Oral Antidiabetic Drugs by Geographic Region, 2017, 2022 & 2028
2.1.3 World Current & Future Analysis for Oral Antidiabetic Drugs by Country/Region, 2017, 2022 & 2028
2.2 Oral Antidiabetic Drugs Segment by Type
2.2.1 Sulfonylureas
2.2.2 Meglitinides
2.2.3 Alpha-glucosidase inhibitors
2.3 Oral Antidiabetic Drugs Sales by Type
2.3.1 Global Oral Antidiabetic Drugs Sales Market Share by Type (2017-2022)
2.3.2 Global Oral Antidiabetic Drugs Revenue and Market Share by Type (2017-2022)
2.3.3 Global Oral Antidiabetic Drugs Sale Price by Type (2017-2022)
2.4 Oral Antidiabetic Drugs Segment by Application
2.4.1 Hospitals
2.4.2 Clinics
2.4.3 Others
2.5 Oral Antidiabetic Drugs Sales by Application
2.5.1 Global Oral Antidiabetic Drugs Sale Market Share by Application (2017-2022)
2.5.2 Global Oral Antidiabetic Drugs Revenue and Market Share by Application (2017-2022)
2.5.3 Global Oral Antidiabetic Drugs Sale Price by Application (2017-2022)
3 GLOBAL ORAL ANTIDIABETIC DRUGS BY COMPANY
3.1 Global Oral Antidiabetic Drugs Breakdown Data by Company
3.1.1 Global Oral Antidiabetic Drugs Annual Sales by Company (2020-2022)
3.1.2 Global Oral Antidiabetic Drugs Sales Market Share by Company (2020-2022)
3.2 Global Oral Antidiabetic Drugs Annual Revenue by Company (2020-2022)
3.2.1 Global Oral Antidiabetic Drugs Revenue by Company (2020-2022)
3.2.2 Global Oral Antidiabetic Drugs Revenue Market Share by Company (2020-2022)
3.3 Global Oral Antidiabetic Drugs Sale Price by Company
3.4 Key Manufacturers Oral Antidiabetic Drugs Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Oral Antidiabetic Drugs Product Location Distribution
3.4.2 Players Oral Antidiabetic Drugs Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 WORLD HISTORIC REVIEW FOR ORAL ANTIDIABETIC DRUGS BY GEOGRAPHIC REGION
4.1 World Historic Oral Antidiabetic Drugs Market Size by Geographic Region (2017-2022)
4.1.1 Global Oral Antidiabetic Drugs Annual Sales by Geographic Region (2017-2022)
4.1.2 Global Oral Antidiabetic Drugs Annual Revenue by Geographic Region
4.2 World Historic Oral Antidiabetic Drugs Market Size by Country/Region (2017-2022)
4.2.1 Global Oral Antidiabetic Drugs Annual Sales by Country/Region (2017-2022)
4.2.2 Global Oral Antidiabetic Drugs Annual Revenue by Country/Region
4.3 Americas Oral Antidiabetic Drugs Sales Growth
4.4 APAC Oral Antidiabetic Drugs Sales Growth
4.5 Europe Oral Antidiabetic Drugs Sales Growth
4.6 Middle East & Africa Oral Antidiabetic Drugs Sales Growth
5 AMERICAS
5.1 Americas Oral Antidiabetic Drugs Sales by Country
5.1.1 Americas Oral Antidiabetic Drugs Sales by Country (2017-2022)
5.1.2 Americas Oral Antidiabetic Drugs Revenue by Country (2017-2022)
5.2 Americas Oral Antidiabetic Drugs Sales by Type
5.3 Americas Oral Antidiabetic Drugs Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Oral Antidiabetic Drugs Sales by Region
6.1.1 APAC Oral Antidiabetic Drugs Sales by Region (2017-2022)
6.1.2 APAC Oral Antidiabetic Drugs Revenue by Region (2017-2022)
6.2 APAC Oral Antidiabetic Drugs Sales by Type
6.3 APAC Oral Antidiabetic Drugs Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Oral Antidiabetic Drugs by Country
7.1.1 Europe Oral Antidiabetic Drugs Sales by Country (2017-2022)
7.1.2 Europe Oral Antidiabetic Drugs Revenue by Country (2017-2022)
7.2 Europe Oral Antidiabetic Drugs Sales by Type
7.3 Europe Oral Antidiabetic Drugs Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Oral Antidiabetic Drugs by Country
8.1.1 Middle East & Africa Oral Antidiabetic Drugs Sales by Country (2017-2022)
8.1.2 Middle East & Africa Oral Antidiabetic Drugs Revenue by Country (2017-2022)
8.2 Middle East & Africa Oral Antidiabetic Drugs Sales by Type
8.3 Middle East & Africa Oral Antidiabetic Drugs Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Oral Antidiabetic Drugs
10.3 Manufacturing Process Analysis of Oral Antidiabetic Drugs
10.4 Industry Chain Structure of Oral Antidiabetic Drugs
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Oral Antidiabetic Drugs Distributors
11.3 Oral Antidiabetic Drugs Customer
12 WORLD FORECAST REVIEW FOR ORAL ANTIDIABETIC DRUGS BY GEOGRAPHIC REGION
12.1 Global Oral Antidiabetic Drugs Market Size Forecast by Region
12.1.1 Global Oral Antidiabetic Drugs Forecast by Region (2023-2028)
12.1.2 Global Oral Antidiabetic Drugs Annual Revenue Forecast by Region (2023-2028)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Oral Antidiabetic Drugs Forecast by Type
12.7 Global Oral Antidiabetic Drugs Forecast by Application
13 KEY PLAYERS ANALYSIS
13.1 Eli Lilly
13.1.1 Eli Lilly Company Information
13.1.2 Eli Lilly Oral Antidiabetic Drugs Product Offered
13.1.3 Eli Lilly Oral Antidiabetic Drugs Sales, Revenue, Price and Gross Margin (2020-2022)
13.1.4 Eli Lilly Main Business Overview
13.1.5 Eli Lilly Latest Developments
13.2 Abbott
13.2.1 Abbott Company Information
13.2.2 Abbott Oral Antidiabetic Drugs Product Offered
13.2.3 Abbott Oral Antidiabetic Drugs Sales, Revenue, Price and Gross Margin (2020-2022)
13.2.4 Abbott Main Business Overview
13.2.5 Abbott Latest Developments
13.3 Biocon
13.3.1 Biocon Company Information
13.3.2 Biocon Oral Antidiabetic Drugs Product Offered
13.3.3 Biocon Oral Antidiabetic Drugs Sales, Revenue, Price and Gross Margin (2020-2022)
13.3.4 Biocon Main Business Overview
13.3.5 Biocon Latest Developments
13.4 Sanofi
13.4.1 Sanofi Company Information
13.4.2 Sanofi Oral Antidiabetic Drugs Product Offered
13.4.3 Sanofi Oral Antidiabetic Drugs Sales, Revenue, Price and Gross Margin (2020-2022)
13.4.4 Sanofi Main Business Overview
13.4.5 Sanofi Latest Developments
13.5 Sunpharma
13.5.1 Sunpharma Company Information
13.5.2 Sunpharma Oral Antidiabetic Drugs Product Offered
13.5.3 Sunpharma Oral Antidiabetic Drugs Sales, Revenue, Price and Gross Margin (2020-2022)
13.5.4 Sunpharma Main Business Overview
13.5.5 Sunpharma Latest Developments
13.6 Novartis
13.6.1 Novartis Company Information
13.6.2 Novartis Oral Antidiabetic Drugs Product Offered
13.6.3 Novartis Oral Antidiabetic Drugs Sales, Revenue, Price and Gross Margin (2020-2022)
13.6.4 Novartis Main Business Overview
13.6.5 Novartis Latest Developments
13.7 Novo Nordisk
13.7.1 Novo Nordisk Company Information
13.7.2 Novo Nordisk Oral Antidiabetic Drugs Product Offered
13.7.3 Novo Nordisk Oral Antidiabetic Drugs Sales, Revenue, Price and Gross Margin (2020-2022)
13.7.4 Novo Nordisk Main Business Overview
13.7.5 Novo Nordisk Latest Developments
13.8 Merck
13.8.1 Merck Company Information
13.8.2 Merck Oral Antidiabetic Drugs Product Offered
13.8.3 Merck Oral Antidiabetic Drugs Sales, Revenue, Price and Gross Margin (2020-2022)
13.8.4 Merck Main Business Overview
13.8.5 Merck Latest Developments
13.9 Pfizer
13.9.1 Pfizer Company Information
13.9.2 Pfizer Oral Antidiabetic Drugs Product Offered
13.9.3 Pfizer Oral Antidiabetic Drugs Sales, Revenue, Price and Gross Margin (2020-2022)
13.9.4 Pfizer Main Business Overview
13.9.5 Pfizer Latest Developments
13.10 Huadong Medicine Co.,Ltd.
13.10.1 Huadong Medicine Co.,Ltd. Company Information
13.10.2 Huadong Medicine Co.,Ltd. Oral Antidiabetic Drugs Product Offered
13.10.3 Huadong Medicine Co.,Ltd. Oral Antidiabetic Drugs Sales, Revenue, Price and Gross Margin (2020-2022)
13.10.4 Huadong Medicine Co.,Ltd. Main Business Overview
13.10.5 Huadong Medicine Co.,Ltd. Latest Developments
13.11 Lepu Medical
13.11.1 Lepu Medical Company Information
13.11.2 Lepu Medical Oral Antidiabetic Drugs Product Offered
13.11.3 Lepu Medical Oral Antidiabetic Drugs Sales, Revenue, Price and Gross Margin (2020-2022)
13.11.4 Lepu Medical Main Business Overview
13.11.5 Lepu Medical Latest Developments
13.12 Hengrui Medicine
13.12.1 Hengrui Medicine Company Information
13.12.2 Hengrui Medicine Oral Antidiabetic Drugs Product Offered
13.12.3 Hengrui Medicine Oral Antidiabetic Drugs Sales, Revenue, Price and Gross Margin (2020-2022)
13.12.4 Hengrui Medicine Main Business Overview
13.12.5 Hengrui Medicine Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. Oral Antidiabetic Drugs Annual Sales CAGR by Geographic Region (2017, 2022 & 2028) & ($ millions)
Table 2. Oral Antidiabetic Drugs Annual Sales CAGR by Country/Region (2017, 2022 & 2028) & ($ millions)
Table 3. Major Players of Sulfonylureas
Table 4. Major Players of Meglitinides
Table 5. Major Players of Alpha-glucosidase inhibitors
Table 6. Global Oral Antidiabetic Drugs Sales by Type (2017-2022) & (K Units)
Table 7. Global Oral Antidiabetic Drugs Sales Market Share by Type (2017-2022)
Table 8. Global Oral Antidiabetic Drugs Revenue by Type (2017-2022) & ($ million)
Table 9. Global Oral Antidiabetic Drugs Revenue Market Share by Type (2017-2022)
Table 10. Global Oral Antidiabetic Drugs Sale Price by Type (2017-2022) & (US$/Unit)
Table 11. Global Oral Antidiabetic Drugs Sales by Application (2017-2022) & (K Units)
Table 12. Global Oral Antidiabetic Drugs Sales Market Share by Application (2017-2022)
Table 13. Global Oral Antidiabetic Drugs Revenue by Application (2017-2022)
Table 14. Global Oral Antidiabetic Drugs Revenue Market Share by Application (2017-2022)
Table 15. Global Oral Antidiabetic Drugs Sale Price by Application (2017-2022) & (US$/Unit)
Table 16. Global Oral Antidiabetic Drugs Sales by Company (2020-2022) & (K Units)
Table 17. Global Oral Antidiabetic Drugs Sales Market Share by Company (2020-2022)
Table 18. Global Oral Antidiabetic Drugs Revenue by Company (2020-2022) ($ Millions)
Table 19. Global Oral Antidiabetic Drugs Revenue Market Share by Company (2020-2022)
Table 20. Global Oral Antidiabetic Drugs Sale Price by Company (2020-2022) & (US$/Unit)
Table 21. Key Manufacturers Oral Antidiabetic Drugs Producing Area Distribution and Sales Area
Table 22. Players Oral Antidiabetic Drugs Products Offered
Table 23. Oral Antidiabetic Drugs Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
Table 24. New Products and Potential Entrants
Table 25. Mergers & Acquisitions, Expansion
Table 26. Global Oral Antidiabetic Drugs Sales by Geographic Region (2017-2022) & (K Units)
Table 27. Global Oral Antidiabetic Drugs Sales Market Share Geographic Region (2017-2022)
Table 28. Global Oral Antidiabetic Drugs Revenue by Geographic Region (2017-2022) & ($ millions)
Table 29. Global Oral Antidiabetic Drugs Revenue Market Share by Geographic Region (2017-2022)
Table 30. Global Oral Antidiabetic Drugs Sales by Country/Region (2017-2022) & (K Units)
Table 31. Global Oral Antidiabetic Drugs Sales Market Share by Country/Region (2017-2022)
Table 32. Global Oral Antidiabetic Drugs Revenue by Country/Region (2017-2022) & ($ millions)
Table 33. Global Oral Antidiabetic Drugs Revenue Market Share by Country/Region (2017-2022)
Table 34. Americas Oral Antidiabetic Drugs Sales by Country (2017-2022) & (K Units)
Table 35. Americas Oral Antidiabetic Drugs Sales Market Share by Country (2017-2022)
Table 36. Americas Oral Antidiabetic Drugs Revenue by Country (2017-2022) & ($ Millions)
Table 37. Americas Oral Antidiabetic Drugs Revenue Market Share by Country (2017-2022)
Table 38. Americas Oral Antidiabetic Drugs Sales by Type (2017-2022) & (K Units)
Table 39. Americas Oral Antidiabetic Drugs Sales Market Share by Type (2017-2022)
Table 40. Americas Oral Antidiabetic Drugs Sales by Application (2017-2022) & (K Units)
Table 41. Americas Oral Antidiabetic Drugs Sales Market Share by Application (2017-2022)
Table 42. APAC Oral Antidiabetic Drugs Sales by Region (2017-2022) & (K Units)
Table 43. APAC Oral Antidiabetic Drugs Sales Market Share by Region (2017-2022)
Table 44. APAC Oral Antidiabetic Drugs Revenue by Region (2017-2022) & ($ Millions)
Table 45. APAC Oral Antidiabetic Drugs Revenue Market Share by Region (2017-2022)
Table 46. APAC Oral Antidiabetic Drugs Sales by Type (2017-2022) & (K Units)
Table 47. APAC Oral Antidiabetic Drugs Sales Market Share by Type (2017-2022)
Table 48. APAC Oral Antidiabetic Drugs Sales by Application (2017-2022) & (K Units)
Table 49. APAC Oral Antidiabetic Drugs Sales Market Share by Application (2017-2022)
Table 50. Europe Oral Antidiabetic Drugs Sales by Country (2017-2022) & (K Units)
Table 51. Europe Oral Antidiabetic Drugs Sales Market Share by Country (2017-2022)
Table 52. Europe Oral Antidiabetic Drugs Revenue by Country (2017-2022) & ($ Millions)
Table 53. Europe Oral Antidiabetic Drugs Revenue Market Share by Country (2017-2022)
Table 54. Europe Oral Antidiabetic Drugs Sales by Type (2017-2022) & (K Units)
Table 55. Europe Oral Antidiabetic Drugs Sales Market Share by Type (2017-2022)
Table 56. Europe Oral Antidiabetic Drugs Sales by Application (2017-2022) & (K Units)
Table 57. Europe Oral Antidiabetic Drugs Sales Market Share by Application (2017-2022)
Table 58. Middle East & Africa Oral Antidiabetic Drugs Sales by Country (2017-2022) & (K Units)
Table 59. Middle East & Africa Oral Antidiabetic Drugs Sales Market Share by Country (2017-2022)
Table 60. Middle East & Africa Oral Antidiabetic Drugs Revenue by Country (2017-2022) & ($ Millions)
Table 61. Middle East & Africa Oral Antidiabetic Drugs Revenue Market Share by Country (2017-2022)
Table 62. Middle East & Africa Oral Antidiabetic Drugs Sales by Type (2017-2022) & (K Units)
Table 63. Middle East & Africa Oral Antidiabetic Drugs Sales Market Share by Type (2017-2022)
Table 64. Middle East & Africa Oral Antidiabetic Drugs Sales by Application (2017-2022) & (K Units)
Table 65. Middle East & Africa Oral Antidiabetic Drugs Sales Market Share by Application (2017-2022)
Table 66. Key Market Drivers & Growth Opportunities of Oral Antidiabetic Drugs
Table 67. Key Market Challenges & Risks of Oral Antidiabetic Drugs
Table 68. Key Industry Trends of Oral Antidiabetic Drugs
Table 69. Oral Antidiabetic Drugs Raw Material
Table 70. Key Suppliers of Raw Materials
Table 71. Oral Antidiabetic Drugs Distributors List
Table 72. Oral Antidiabetic Drugs Customer List
Table 73. Global Oral Antidiabetic Drugs Sales Forecast by Region (2023-2028) & (K Units)
Table 74. Global Oral Antidiabetic Drugs Sales Market Forecast by Region
Table 75. Global Oral Antidiabetic Drugs Revenue Forecast by Region (2023-2028) & ($ millions)
Table 76. Global Oral Antidiabetic Drugs Revenue Market Share Forecast by Region (2023-2028)
Table 77. Americas Oral Antidiabetic Drugs Sales Forecast by Country (2023-2028) & (K Units)
Table 78. Americas Oral Antidiabetic Drugs Revenue Forecast by Country (2023-2028) & ($ millions)
Table 79. APAC Oral Antidiabetic Drugs Sales Forecast by Region (2023-2028) & (K Units)
Table 80. APAC Oral Antidiabetic Drugs Revenue Forecast by Region (2023-2028) & ($ millions)
Table 81. Europe Oral Antidiabetic Drugs Sales Forecast by Country (2023-2028) & (K Units)
Table 82. Europe Oral Antidiabetic Drugs Revenue Forecast by Country (2023-2028) & ($ millions)
Table 83. Middle East & Africa Oral Antidiabetic Drugs Sales Forecast by Country (2023-2028) & (K Units)
Table 84. Middle East & Africa Oral Antidiabetic Drugs Revenue Forecast by Country (2023-2028) & ($ millions)
Table 85. Global Oral Antidiabetic Drugs Sales Forecast by Type (2023-2028) & (K Units)
Table 86. Global Oral Antidiabetic Drugs Sales Market Share Forecast by Type (2023-2028)
Table 87. Global Oral Antidiabetic Drugs Revenue Forecast by Type (2023-2028) & ($ Millions)
Table 88. Global Oral Antidiabetic Drugs Revenue Market Share Forecast by Type (2023-2028)
Table 89. Global Oral Antidiabetic Drugs Sales Forecast by Application (2023-2028) & (K Units)
Table 90. Global Oral Antidiabetic Drugs Sales Market Share Forecast by Application (2023-2028)
Table 91. Global Oral Antidiabetic Drugs Revenue Forecast by Application (2023-2028) & ($ Millions)
Table 92. Global Oral Antidiabetic Drugs Revenue Market Share Forecast by Application (2023-2028)
Table 93. Eli Lilly Basic Information, Oral Antidiabetic Drugs Manufacturing Base, Sales Area and Its Competitors
Table 94. Eli Lilly Oral Antidiabetic Drugs Product Offered
Table 95. Eli Lilly Oral Antidiabetic Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 96. Eli Lilly Main Business
Table 97. Eli Lilly Latest Developments
Table 98. Abbott Basic Information, Oral Antidiabetic Drugs Manufacturing Base, Sales Area and Its Competitors
Table 99. Abbott Oral Antidiabetic Drugs Product Offered
Table 100. Abbott Oral Antidiabetic Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 101. Abbott Main Business
Table 102. Abbott Latest Developments
Table 103. Biocon Basic Information, Oral Antidiabetic Drugs Manufacturing Base, Sales Area and Its Competitors
Table 104. Biocon Oral Antidiabetic Drugs Product Offered
Table 105. Biocon Oral Antidiabetic Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 106. Biocon Main Business
Table 107. Biocon Latest Developments
Table 108. Sanofi Basic Information, Oral Antidiabetic Drugs Manufacturing Base, Sales Area and Its Competitors
Table 109. Sanofi Oral Antidiabetic Drugs Product Offered
Table 110. Sanofi Oral Antidiabetic Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 111. Sanofi Main Business
Table 112. Sanofi Latest Developments
Table 113. Sunpharma Basic Information, Oral Antidiabetic Drugs Manufacturing Base, Sales Area and Its Competitors
Table 114. Sunpharma Oral Antidiabetic Drugs Product Offered
Table 115. Sunpharma Oral Antidiabetic Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 116. Sunpharma Main Business
Table 117. Sunpharma Latest Developments
Table 118. Novartis Basic Information, Oral Antidiabetic Drugs Manufacturing Base, Sales Area and Its Competitors
Table 119. Novartis Oral Antidiabetic Drugs Product Offered
Table 120. Novartis Oral Antidiabetic Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 121. Novartis Main Business
Table 122. Novartis Latest Developments
Table 123. Novo Nordisk Basic Information, Oral Antidiabetic Drugs Manufacturing Base, Sales Area and Its Competitors
Table 124. Novo Nordisk Oral Antidiabetic Drugs Product Offered
Table 125. Novo Nordisk Oral Antidiabetic Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 126. Novo Nordisk Main Business
Table 127. Novo Nordisk Latest Developments
Table 128. Merck Basic Information, Oral Antidiabetic Drugs Manufacturing Base, Sales Area and Its Competitors
Table 129. Merck Oral Antidiabetic Drugs Product Offered
Table 130. Merck Oral Antidiabetic Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 131. Merck Main Business
Table 132. Merck Latest Developments
Table 133. Pfizer Basic Information, Oral Antidiabetic Drugs Manufacturing Base, Sales Area and Its Competitors
Table 134. Pfizer Oral Antidiabetic Drugs Product Offered
Table 135. Pfizer Oral Antidiabetic Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 136. Pfizer Main Business
Table 137. Pfizer Latest Developments
Table 138. Huadong Medicine Co.,Ltd. Basic Information, Oral Antidiabetic Drugs Manufacturing Base, Sales Area and Its Competitors
Table 139. Huadong Medicine Co.,Ltd. Oral Antidiabetic Drugs Product Offered
Table 140. Huadong Medicine Co.,Ltd. Oral Antidiabetic Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 141. Huadong Medicine Co.,Ltd. Main Business
Table 142. Huadong Medicine Co.,Ltd. Latest Developments
Table 143. Lepu Medical Basic Information, Oral Antidiabetic Drugs Manufacturing Base, Sales Area and Its Competitors
Table 144. Lepu Medical Oral Antidiabetic Drugs Product Offered
Table 145. Lepu Medical Oral Antidiabetic Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 146. Lepu Medical Main Business
Table 147. Lepu Medical Latest Developments
Table 148. Hengrui Medicine Basic Information, Oral Antidiabetic Drugs Manufacturing Base, Sales Area and Its Competitors
Table 149. Hengrui Medicine Oral Antidiabetic Drugs Product Offered
Table 150. Hengrui Medicine Oral Antidiabetic Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 151. Hengrui Medicine Main Business
Table 152. Hengrui Medicine Latest Developments
Table 1. Oral Antidiabetic Drugs Annual Sales CAGR by Geographic Region (2017, 2022 & 2028) & ($ millions)
Table 2. Oral Antidiabetic Drugs Annual Sales CAGR by Country/Region (2017, 2022 & 2028) & ($ millions)
Table 3. Major Players of Sulfonylureas
Table 4. Major Players of Meglitinides
Table 5. Major Players of Alpha-glucosidase inhibitors
Table 6. Global Oral Antidiabetic Drugs Sales by Type (2017-2022) & (K Units)
Table 7. Global Oral Antidiabetic Drugs Sales Market Share by Type (2017-2022)
Table 8. Global Oral Antidiabetic Drugs Revenue by Type (2017-2022) & ($ million)
Table 9. Global Oral Antidiabetic Drugs Revenue Market Share by Type (2017-2022)
Table 10. Global Oral Antidiabetic Drugs Sale Price by Type (2017-2022) & (US$/Unit)
Table 11. Global Oral Antidiabetic Drugs Sales by Application (2017-2022) & (K Units)
Table 12. Global Oral Antidiabetic Drugs Sales Market Share by Application (2017-2022)
Table 13. Global Oral Antidiabetic Drugs Revenue by Application (2017-2022)
Table 14. Global Oral Antidiabetic Drugs Revenue Market Share by Application (2017-2022)
Table 15. Global Oral Antidiabetic Drugs Sale Price by Application (2017-2022) & (US$/Unit)
Table 16. Global Oral Antidiabetic Drugs Sales by Company (2020-2022) & (K Units)
Table 17. Global Oral Antidiabetic Drugs Sales Market Share by Company (2020-2022)
Table 18. Global Oral Antidiabetic Drugs Revenue by Company (2020-2022) ($ Millions)
Table 19. Global Oral Antidiabetic Drugs Revenue Market Share by Company (2020-2022)
Table 20. Global Oral Antidiabetic Drugs Sale Price by Company (2020-2022) & (US$/Unit)
Table 21. Key Manufacturers Oral Antidiabetic Drugs Producing Area Distribution and Sales Area
Table 22. Players Oral Antidiabetic Drugs Products Offered
Table 23. Oral Antidiabetic Drugs Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
Table 24. New Products and Potential Entrants
Table 25. Mergers & Acquisitions, Expansion
Table 26. Global Oral Antidiabetic Drugs Sales by Geographic Region (2017-2022) & (K Units)
Table 27. Global Oral Antidiabetic Drugs Sales Market Share Geographic Region (2017-2022)
Table 28. Global Oral Antidiabetic Drugs Revenue by Geographic Region (2017-2022) & ($ millions)
Table 29. Global Oral Antidiabetic Drugs Revenue Market Share by Geographic Region (2017-2022)
Table 30. Global Oral Antidiabetic Drugs Sales by Country/Region (2017-2022) & (K Units)
Table 31. Global Oral Antidiabetic Drugs Sales Market Share by Country/Region (2017-2022)
Table 32. Global Oral Antidiabetic Drugs Revenue by Country/Region (2017-2022) & ($ millions)
Table 33. Global Oral Antidiabetic Drugs Revenue Market Share by Country/Region (2017-2022)
Table 34. Americas Oral Antidiabetic Drugs Sales by Country (2017-2022) & (K Units)
Table 35. Americas Oral Antidiabetic Drugs Sales Market Share by Country (2017-2022)
Table 36. Americas Oral Antidiabetic Drugs Revenue by Country (2017-2022) & ($ Millions)
Table 37. Americas Oral Antidiabetic Drugs Revenue Market Share by Country (2017-2022)
Table 38. Americas Oral Antidiabetic Drugs Sales by Type (2017-2022) & (K Units)
Table 39. Americas Oral Antidiabetic Drugs Sales Market Share by Type (2017-2022)
Table 40. Americas Oral Antidiabetic Drugs Sales by Application (2017-2022) & (K Units)
Table 41. Americas Oral Antidiabetic Drugs Sales Market Share by Application (2017-2022)
Table 42. APAC Oral Antidiabetic Drugs Sales by Region (2017-2022) & (K Units)
Table 43. APAC Oral Antidiabetic Drugs Sales Market Share by Region (2017-2022)
Table 44. APAC Oral Antidiabetic Drugs Revenue by Region (2017-2022) & ($ Millions)
Table 45. APAC Oral Antidiabetic Drugs Revenue Market Share by Region (2017-2022)
Table 46. APAC Oral Antidiabetic Drugs Sales by Type (2017-2022) & (K Units)
Table 47. APAC Oral Antidiabetic Drugs Sales Market Share by Type (2017-2022)
Table 48. APAC Oral Antidiabetic Drugs Sales by Application (2017-2022) & (K Units)
Table 49. APAC Oral Antidiabetic Drugs Sales Market Share by Application (2017-2022)
Table 50. Europe Oral Antidiabetic Drugs Sales by Country (2017-2022) & (K Units)
Table 51. Europe Oral Antidiabetic Drugs Sales Market Share by Country (2017-2022)
Table 52. Europe Oral Antidiabetic Drugs Revenue by Country (2017-2022) & ($ Millions)
Table 53. Europe Oral Antidiabetic Drugs Revenue Market Share by Country (2017-2022)
Table 54. Europe Oral Antidiabetic Drugs Sales by Type (2017-2022) & (K Units)
Table 55. Europe Oral Antidiabetic Drugs Sales Market Share by Type (2017-2022)
Table 56. Europe Oral Antidiabetic Drugs Sales by Application (2017-2022) & (K Units)
Table 57. Europe Oral Antidiabetic Drugs Sales Market Share by Application (2017-2022)
Table 58. Middle East & Africa Oral Antidiabetic Drugs Sales by Country (2017-2022) & (K Units)
Table 59. Middle East & Africa Oral Antidiabetic Drugs Sales Market Share by Country (2017-2022)
Table 60. Middle East & Africa Oral Antidiabetic Drugs Revenue by Country (2017-2022) & ($ Millions)
Table 61. Middle East & Africa Oral Antidiabetic Drugs Revenue Market Share by Country (2017-2022)
Table 62. Middle East & Africa Oral Antidiabetic Drugs Sales by Type (2017-2022) & (K Units)
Table 63. Middle East & Africa Oral Antidiabetic Drugs Sales Market Share by Type (2017-2022)
Table 64. Middle East & Africa Oral Antidiabetic Drugs Sales by Application (2017-2022) & (K Units)
Table 65. Middle East & Africa Oral Antidiabetic Drugs Sales Market Share by Application (2017-2022)
Table 66. Key Market Drivers & Growth Opportunities of Oral Antidiabetic Drugs
Table 67. Key Market Challenges & Risks of Oral Antidiabetic Drugs
Table 68. Key Industry Trends of Oral Antidiabetic Drugs
Table 69. Oral Antidiabetic Drugs Raw Material
Table 70. Key Suppliers of Raw Materials
Table 71. Oral Antidiabetic Drugs Distributors List
Table 72. Oral Antidiabetic Drugs Customer List
Table 73. Global Oral Antidiabetic Drugs Sales Forecast by Region (2023-2028) & (K Units)
Table 74. Global Oral Antidiabetic Drugs Sales Market Forecast by Region
Table 75. Global Oral Antidiabetic Drugs Revenue Forecast by Region (2023-2028) & ($ millions)
Table 76. Global Oral Antidiabetic Drugs Revenue Market Share Forecast by Region (2023-2028)
Table 77. Americas Oral Antidiabetic Drugs Sales Forecast by Country (2023-2028) & (K Units)
Table 78. Americas Oral Antidiabetic Drugs Revenue Forecast by Country (2023-2028) & ($ millions)
Table 79. APAC Oral Antidiabetic Drugs Sales Forecast by Region (2023-2028) & (K Units)
Table 80. APAC Oral Antidiabetic Drugs Revenue Forecast by Region (2023-2028) & ($ millions)
Table 81. Europe Oral Antidiabetic Drugs Sales Forecast by Country (2023-2028) & (K Units)
Table 82. Europe Oral Antidiabetic Drugs Revenue Forecast by Country (2023-2028) & ($ millions)
Table 83. Middle East & Africa Oral Antidiabetic Drugs Sales Forecast by Country (2023-2028) & (K Units)
Table 84. Middle East & Africa Oral Antidiabetic Drugs Revenue Forecast by Country (2023-2028) & ($ millions)
Table 85. Global Oral Antidiabetic Drugs Sales Forecast by Type (2023-2028) & (K Units)
Table 86. Global Oral Antidiabetic Drugs Sales Market Share Forecast by Type (2023-2028)
Table 87. Global Oral Antidiabetic Drugs Revenue Forecast by Type (2023-2028) & ($ Millions)
Table 88. Global Oral Antidiabetic Drugs Revenue Market Share Forecast by Type (2023-2028)
Table 89. Global Oral Antidiabetic Drugs Sales Forecast by Application (2023-2028) & (K Units)
Table 90. Global Oral Antidiabetic Drugs Sales Market Share Forecast by Application (2023-2028)
Table 91. Global Oral Antidiabetic Drugs Revenue Forecast by Application (2023-2028) & ($ Millions)
Table 92. Global Oral Antidiabetic Drugs Revenue Market Share Forecast by Application (2023-2028)
Table 93. Eli Lilly Basic Information, Oral Antidiabetic Drugs Manufacturing Base, Sales Area and Its Competitors
Table 94. Eli Lilly Oral Antidiabetic Drugs Product Offered
Table 95. Eli Lilly Oral Antidiabetic Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 96. Eli Lilly Main Business
Table 97. Eli Lilly Latest Developments
Table 98. Abbott Basic Information, Oral Antidiabetic Drugs Manufacturing Base, Sales Area and Its Competitors
Table 99. Abbott Oral Antidiabetic Drugs Product Offered
Table 100. Abbott Oral Antidiabetic Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 101. Abbott Main Business
Table 102. Abbott Latest Developments
Table 103. Biocon Basic Information, Oral Antidiabetic Drugs Manufacturing Base, Sales Area and Its Competitors
Table 104. Biocon Oral Antidiabetic Drugs Product Offered
Table 105. Biocon Oral Antidiabetic Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 106. Biocon Main Business
Table 107. Biocon Latest Developments
Table 108. Sanofi Basic Information, Oral Antidiabetic Drugs Manufacturing Base, Sales Area and Its Competitors
Table 109. Sanofi Oral Antidiabetic Drugs Product Offered
Table 110. Sanofi Oral Antidiabetic Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 111. Sanofi Main Business
Table 112. Sanofi Latest Developments
Table 113. Sunpharma Basic Information, Oral Antidiabetic Drugs Manufacturing Base, Sales Area and Its Competitors
Table 114. Sunpharma Oral Antidiabetic Drugs Product Offered
Table 115. Sunpharma Oral Antidiabetic Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 116. Sunpharma Main Business
Table 117. Sunpharma Latest Developments
Table 118. Novartis Basic Information, Oral Antidiabetic Drugs Manufacturing Base, Sales Area and Its Competitors
Table 119. Novartis Oral Antidiabetic Drugs Product Offered
Table 120. Novartis Oral Antidiabetic Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 121. Novartis Main Business
Table 122. Novartis Latest Developments
Table 123. Novo Nordisk Basic Information, Oral Antidiabetic Drugs Manufacturing Base, Sales Area and Its Competitors
Table 124. Novo Nordisk Oral Antidiabetic Drugs Product Offered
Table 125. Novo Nordisk Oral Antidiabetic Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 126. Novo Nordisk Main Business
Table 127. Novo Nordisk Latest Developments
Table 128. Merck Basic Information, Oral Antidiabetic Drugs Manufacturing Base, Sales Area and Its Competitors
Table 129. Merck Oral Antidiabetic Drugs Product Offered
Table 130. Merck Oral Antidiabetic Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 131. Merck Main Business
Table 132. Merck Latest Developments
Table 133. Pfizer Basic Information, Oral Antidiabetic Drugs Manufacturing Base, Sales Area and Its Competitors
Table 134. Pfizer Oral Antidiabetic Drugs Product Offered
Table 135. Pfizer Oral Antidiabetic Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 136. Pfizer Main Business
Table 137. Pfizer Latest Developments
Table 138. Huadong Medicine Co.,Ltd. Basic Information, Oral Antidiabetic Drugs Manufacturing Base, Sales Area and Its Competitors
Table 139. Huadong Medicine Co.,Ltd. Oral Antidiabetic Drugs Product Offered
Table 140. Huadong Medicine Co.,Ltd. Oral Antidiabetic Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 141. Huadong Medicine Co.,Ltd. Main Business
Table 142. Huadong Medicine Co.,Ltd. Latest Developments
Table 143. Lepu Medical Basic Information, Oral Antidiabetic Drugs Manufacturing Base, Sales Area and Its Competitors
Table 144. Lepu Medical Oral Antidiabetic Drugs Product Offered
Table 145. Lepu Medical Oral Antidiabetic Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 146. Lepu Medical Main Business
Table 147. Lepu Medical Latest Developments
Table 148. Hengrui Medicine Basic Information, Oral Antidiabetic Drugs Manufacturing Base, Sales Area and Its Competitors
Table 149. Hengrui Medicine Oral Antidiabetic Drugs Product Offered
Table 150. Hengrui Medicine Oral Antidiabetic Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 151. Hengrui Medicine Main Business
Table 152. Hengrui Medicine Latest Developments
LIST OF FIGURES
Figure 1. Picture of Oral Antidiabetic Drugs
Figure 2. Oral Antidiabetic Drugs Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Oral Antidiabetic Drugs Sales Growth Rate 2017-2028 (K Units)
Figure 7. Global Oral Antidiabetic Drugs Revenue Growth Rate 2017-2028 ($ Millions)
Figure 8. Oral Antidiabetic Drugs Sales by Region (2021 & 2028) & ($ millions)
Figure 9. Product Picture of Sulfonylureas
Figure 10. Product Picture of Meglitinides
Figure 11. Product Picture of Alpha-glucosidase inhibitors
Figure 12. Global Oral Antidiabetic Drugs Sales Market Share by Type in 2021
Figure 13. Global Oral Antidiabetic Drugs Revenue Market Share by Type (2017-2022)
Figure 14. Oral Antidiabetic Drugs Consumed in Hospitals
Figure 15. Global Oral Antidiabetic Drugs Market: Hospitals (2017-2022) & (K Units)
Figure 16. Oral Antidiabetic Drugs Consumed in Clinics
Figure 17. Global Oral Antidiabetic Drugs Market: Clinics (2017-2022) & (K Units)
Figure 18. Oral Antidiabetic Drugs Consumed in Others
Figure 19. Global Oral Antidiabetic Drugs Market: Others (2017-2022) & (K Units)
Figure 20. Global Oral Antidiabetic Drugs Sales Market Share by Application (2017-2022)
Figure 21. Global Oral Antidiabetic Drugs Revenue Market Share by Application in 2021
Figure 22. Oral Antidiabetic Drugs Revenue Market by Company in 2021 ($ Million)
Figure 23. Global Oral Antidiabetic Drugs Revenue Market Share by Company in 2021
Figure 24. Global Oral Antidiabetic Drugs Sales Market Share by Geographic Region (2017-2022)
Figure 25. Global Oral Antidiabetic Drugs Revenue Market Share by Geographic Region in 2021
Figure 26. Global Oral Antidiabetic Drugs Sales Market Share by Region (2017-2022)
Figure 27. Global Oral Antidiabetic Drugs Revenue Market Share by Country/Region in 2021
Figure 28. Americas Oral Antidiabetic Drugs Sales 2017-2022 (K Units)
Figure 29. Americas Oral Antidiabetic Drugs Revenue 2017-2022 ($ Millions)
Figure 30. APAC Oral Antidiabetic Drugs Sales 2017-2022 (K Units)
Figure 31. APAC Oral Antidiabetic Drugs Revenue 2017-2022 ($ Millions)
Figure 32. Europe Oral Antidiabetic Drugs Sales 2017-2022 (K Units)
Figure 33. Europe Oral Antidiabetic Drugs Revenue 2017-2022 ($ Millions)
Figure 34. Middle East & Africa Oral Antidiabetic Drugs Sales 2017-2022 (K Units)
Figure 35. Middle East & Africa Oral Antidiabetic Drugs Revenue 2017-2022 ($ Millions)
Figure 36. Americas Oral Antidiabetic Drugs Sales Market Share by Country in 2021
Figure 37. Americas Oral Antidiabetic Drugs Revenue Market Share by Country in 2021
Figure 38. United States Oral Antidiabetic Drugs Revenue Growth 2017-2022 ($ Millions)
Figure 39. Canada Oral Antidiabetic Drugs Revenue Growth 2017-2022 ($ Millions)
Figure 40. Mexico Oral Antidiabetic Drugs Revenue Growth 2017-2022 ($ Millions)
Figure 41. Brazil Oral Antidiabetic Drugs Revenue Growth 2017-2022 ($ Millions)
Figure 42. APAC Oral Antidiabetic Drugs Sales Market Share by Region in 2021
Figure 43. APAC Oral Antidiabetic Drugs Revenue Market Share by Regions in 2021
Figure 44. China Oral Antidiabetic Drugs Revenue Growth 2017-2022 ($ Millions)
Figure 45. Japan Oral Antidiabetic Drugs Revenue Growth 2017-2022 ($ Millions)
Figure 46. South Korea Oral Antidiabetic Drugs Revenue Growth 2017-2022 ($ Millions)
Figure 47. Southeast Asia Oral Antidiabetic Drugs Revenue Growth 2017-2022 ($ Millions)
Figure 48. India Oral Antidiabetic Drugs Revenue Growth 2017-2022 ($ Millions)
Figure 49. Australia Oral Antidiabetic Drugs Revenue Growth 2017-2022 ($ Millions)
Figure 50. Europe Oral Antidiabetic Drugs Sales Market Share by Country in 2021
Figure 51. Europe Oral Antidiabetic Drugs Revenue Market Share by Country in 2021
Figure 52. Germany Oral Antidiabetic Drugs Revenue Growth 2017-2022 ($ Millions)
Figure 53. France Oral Antidiabetic Drugs Revenue Growth 2017-2022 ($ Millions)
Figure 54. UK Oral Antidiabetic Drugs Revenue Growth 2017-2022 ($ Millions)
Figure 55. Italy Oral Antidiabetic Drugs Revenue Growth 2017-2022 ($ Millions)
Figure 56. Russia Oral Antidiabetic Drugs Revenue Growth 2017-2022 ($ Millions)
Figure 57. Middle East & Africa Oral Antidiabetic Drugs Sales Market Share by Country in 2021
Figure 58. Middle East & Africa Oral Antidiabetic Drugs Revenue Market Share by Country in 2021
Figure 59. Egypt Oral Antidiabetic Drugs Revenue Growth 2017-2022 ($ Millions)
Figure 60. South Africa Oral Antidiabetic Drugs Revenue Growth 2017-2022 ($ Millions)
Figure 61. Israel Oral Antidiabetic Drugs Revenue Growth 2017-2022 ($ Millions)
Figure 62. Turkey Oral Antidiabetic Drugs Revenue Growth 2017-2022 ($ Millions)
Figure 63. GCC Country Oral Antidiabetic Drugs Revenue Growth 2017-2022 ($ Millions)
Figure 64. Manufacturing Cost Structure Analysis of Oral Antidiabetic Drugs in 2021
Figure 65. Manufacturing Process Analysis of Oral Antidiabetic Drugs
Figure 66. Industry Chain Structure of Oral Antidiabetic Drugs
Figure 67. Channels of Distribution
Figure 68. Distributors Profiles
Figure 1. Picture of Oral Antidiabetic Drugs
Figure 2. Oral Antidiabetic Drugs Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Oral Antidiabetic Drugs Sales Growth Rate 2017-2028 (K Units)
Figure 7. Global Oral Antidiabetic Drugs Revenue Growth Rate 2017-2028 ($ Millions)
Figure 8. Oral Antidiabetic Drugs Sales by Region (2021 & 2028) & ($ millions)
Figure 9. Product Picture of Sulfonylureas
Figure 10. Product Picture of Meglitinides
Figure 11. Product Picture of Alpha-glucosidase inhibitors
Figure 12. Global Oral Antidiabetic Drugs Sales Market Share by Type in 2021
Figure 13. Global Oral Antidiabetic Drugs Revenue Market Share by Type (2017-2022)
Figure 14. Oral Antidiabetic Drugs Consumed in Hospitals
Figure 15. Global Oral Antidiabetic Drugs Market: Hospitals (2017-2022) & (K Units)
Figure 16. Oral Antidiabetic Drugs Consumed in Clinics
Figure 17. Global Oral Antidiabetic Drugs Market: Clinics (2017-2022) & (K Units)
Figure 18. Oral Antidiabetic Drugs Consumed in Others
Figure 19. Global Oral Antidiabetic Drugs Market: Others (2017-2022) & (K Units)
Figure 20. Global Oral Antidiabetic Drugs Sales Market Share by Application (2017-2022)
Figure 21. Global Oral Antidiabetic Drugs Revenue Market Share by Application in 2021
Figure 22. Oral Antidiabetic Drugs Revenue Market by Company in 2021 ($ Million)
Figure 23. Global Oral Antidiabetic Drugs Revenue Market Share by Company in 2021
Figure 24. Global Oral Antidiabetic Drugs Sales Market Share by Geographic Region (2017-2022)
Figure 25. Global Oral Antidiabetic Drugs Revenue Market Share by Geographic Region in 2021
Figure 26. Global Oral Antidiabetic Drugs Sales Market Share by Region (2017-2022)
Figure 27. Global Oral Antidiabetic Drugs Revenue Market Share by Country/Region in 2021
Figure 28. Americas Oral Antidiabetic Drugs Sales 2017-2022 (K Units)
Figure 29. Americas Oral Antidiabetic Drugs Revenue 2017-2022 ($ Millions)
Figure 30. APAC Oral Antidiabetic Drugs Sales 2017-2022 (K Units)
Figure 31. APAC Oral Antidiabetic Drugs Revenue 2017-2022 ($ Millions)
Figure 32. Europe Oral Antidiabetic Drugs Sales 2017-2022 (K Units)
Figure 33. Europe Oral Antidiabetic Drugs Revenue 2017-2022 ($ Millions)
Figure 34. Middle East & Africa Oral Antidiabetic Drugs Sales 2017-2022 (K Units)
Figure 35. Middle East & Africa Oral Antidiabetic Drugs Revenue 2017-2022 ($ Millions)
Figure 36. Americas Oral Antidiabetic Drugs Sales Market Share by Country in 2021
Figure 37. Americas Oral Antidiabetic Drugs Revenue Market Share by Country in 2021
Figure 38. United States Oral Antidiabetic Drugs Revenue Growth 2017-2022 ($ Millions)
Figure 39. Canada Oral Antidiabetic Drugs Revenue Growth 2017-2022 ($ Millions)
Figure 40. Mexico Oral Antidiabetic Drugs Revenue Growth 2017-2022 ($ Millions)
Figure 41. Brazil Oral Antidiabetic Drugs Revenue Growth 2017-2022 ($ Millions)
Figure 42. APAC Oral Antidiabetic Drugs Sales Market Share by Region in 2021
Figure 43. APAC Oral Antidiabetic Drugs Revenue Market Share by Regions in 2021
Figure 44. China Oral Antidiabetic Drugs Revenue Growth 2017-2022 ($ Millions)
Figure 45. Japan Oral Antidiabetic Drugs Revenue Growth 2017-2022 ($ Millions)
Figure 46. South Korea Oral Antidiabetic Drugs Revenue Growth 2017-2022 ($ Millions)
Figure 47. Southeast Asia Oral Antidiabetic Drugs Revenue Growth 2017-2022 ($ Millions)
Figure 48. India Oral Antidiabetic Drugs Revenue Growth 2017-2022 ($ Millions)
Figure 49. Australia Oral Antidiabetic Drugs Revenue Growth 2017-2022 ($ Millions)
Figure 50. Europe Oral Antidiabetic Drugs Sales Market Share by Country in 2021
Figure 51. Europe Oral Antidiabetic Drugs Revenue Market Share by Country in 2021
Figure 52. Germany Oral Antidiabetic Drugs Revenue Growth 2017-2022 ($ Millions)
Figure 53. France Oral Antidiabetic Drugs Revenue Growth 2017-2022 ($ Millions)
Figure 54. UK Oral Antidiabetic Drugs Revenue Growth 2017-2022 ($ Millions)
Figure 55. Italy Oral Antidiabetic Drugs Revenue Growth 2017-2022 ($ Millions)
Figure 56. Russia Oral Antidiabetic Drugs Revenue Growth 2017-2022 ($ Millions)
Figure 57. Middle East & Africa Oral Antidiabetic Drugs Sales Market Share by Country in 2021
Figure 58. Middle East & Africa Oral Antidiabetic Drugs Revenue Market Share by Country in 2021
Figure 59. Egypt Oral Antidiabetic Drugs Revenue Growth 2017-2022 ($ Millions)
Figure 60. South Africa Oral Antidiabetic Drugs Revenue Growth 2017-2022 ($ Millions)
Figure 61. Israel Oral Antidiabetic Drugs Revenue Growth 2017-2022 ($ Millions)
Figure 62. Turkey Oral Antidiabetic Drugs Revenue Growth 2017-2022 ($ Millions)
Figure 63. GCC Country Oral Antidiabetic Drugs Revenue Growth 2017-2022 ($ Millions)
Figure 64. Manufacturing Cost Structure Analysis of Oral Antidiabetic Drugs in 2021
Figure 65. Manufacturing Process Analysis of Oral Antidiabetic Drugs
Figure 66. Industry Chain Structure of Oral Antidiabetic Drugs
Figure 67. Channels of Distribution
Figure 68. Distributors Profiles
